R01 DA024553/DA/NIDA NIH HHS/United States[Grants and Funding] - Search Results

This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Save citations to file

Email citations

Subject: R01 DA024553/DA/NIDA NIH HHS/United States[Grants - PubMed

To:

From:

Selection:

Format:

MeSH and other data

Add to Collections

Add to My Bibliography

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Email: (change)

Frequency:

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Results by year

Year	Number of Results
2011	1
2015	2
2017	6
2018	6
2021	1
2024	0

12 results

Page of 2

Results by year

Page 1

Multivariate pattern analysis links drug use severity to distributed cortical hypoactivity during emotional inhibitory control in opioid use disorder.

Shi Z, Langleben DD, O'Brien CP, Childress AR, Wiers CE. Shi Z, et al. Neuroimage Clin. 2021;32:102806. doi: 10.1016/j.nicl.2021.102806. Epub 2021 Aug 29. Neuroimage Clin. 2021. PMID: 34525436 Free PMC article.

Effects of extended-release naltrexone on the brain response to drug-related stimuli in patients with opioid use disorder.

Shi Z, Wang AL, Jagannathan K, Fairchild VP, O'Brien CP, Childress AR, Langleben DD. Shi Z, et al. J Psychiatry Neurosci. 2018 Jul;43(4):254-261. doi: 10.1503/jpn.170036. J Psychiatry Neurosci. 2018. PMID: 29947607 Free PMC article. Clinical Trial.

Personal Control Over Decisions to Participate in Research by Persons With Histories of Both Substance Use Disorders and Criminal Justice Supervision.

Chen DT, Ko TM, Allen AA, Bonnie RJ, Suratt CE, Appelbaum PS, Nunes EV, Friedmann PD, Lee JD, Gordon MS, McDonald R, Wilson D, Boney TY, Murphy SM, O'Brien CP. Chen DT, et al. J Empir Res Hum Res Ethics. 2018 Apr;13(2):160-172. doi: 10.1177/1556264618755243. Epub 2018 Feb 20. J Empir Res Hum Res Ethics. 2018. PMID: 29460668 Free PMC article.

Effectiveness, Implementation and Real-World Experience with Extended-Release Naltrexone (XR-NTX): A Special Issue of JSAT.

Friedmann PD, Dunn KE, Nunes EV, O'Brien CP. Friedmann PD, et al. J Subst Abuse Treat. 2018 Feb;85:31-33. doi: 10.1016/j.jsat.2017.11.008. Epub 2017 Nov 22. J Subst Abuse Treat. 2018. PMID: 29273249 No abstract available.

Sustained opioid antagonism modulates striatal sensitivity to baby schema in opioid use disorder.

Wang AL, Lowen SB, Elman I, Shi Z, Fairchild VP, Bouril A, Gur RC, Langleben DD. Wang AL, et al. J Subst Abuse Treat. 2018 Feb;85:70-77. doi: 10.1016/j.jsat.2017.10.007. Epub 2017 Oct 18. J Subst Abuse Treat. 2018. PMID: 29146290 Free PMC article.

Assessing informed consent in an opioid relapse prevention study with adults under current or recent criminal justice supervision.

Allen AA, Chen DT, Bonnie RJ, Ko TM, Suratt CE, Lee JD, Friedmann PD, Gordon M, McDonald R, Murphy SM, Boney TY, Nunes EV, O'Brien CP. Allen AA, et al. J Subst Abuse Treat. 2017 Oct;81:66-72. doi: 10.1016/j.jsat.2017.07.015. Epub 2017 Aug 1. J Subst Abuse Treat. 2017. PMID: 28847457 Free PMC article. Clinical Trial.

Relapse to opioid use disorder after inpatient treatment: Protective effect of injection naltrexone.

Nunes EV, Gordon M, Friedmann PD, Fishman MJ, Lee JD, Chen DT, Hu MC, Boney TY, Wilson D, O'Brien CP. Nunes EV, et al. J Subst Abuse Treat. 2018 Feb;85:49-55. doi: 10.1016/j.jsat.2017.04.016. Epub 2017 Apr 23. J Subst Abuse Treat. 2018. PMID: 28473233 Free PMC article.

Cost-effectiveness of extended release naltrexone to prevent relapse among criminal justice-involved individuals with a history of opioid use disorder.

Murphy SM, Polsky D, Lee JD, Friedmann PD, Kinlock TW, Nunes EV, Bonnie RJ, Gordon M, Chen DT, Boney TY, O'Brien CP. Murphy SM, et al. Addiction. 2017 Aug;112(8):1440-1450. doi: 10.1111/add.13807. Epub 2017 Apr 12. Addiction. 2017. PMID: 28239984 Free PMC article. Clinical Trial.

Do patient characteristics moderate the effect of extended-release naltrexone (XR-NTX) for opioid use disorder?

Friedmann PD, Wilson D, Nunes EV, Hoskinson R Jr, Lee JD, Gordon M, Murphy SM, Bonnie RJ, Chen DT, Boney TY, O'Brien CP. Friedmann PD, et al. J Subst Abuse Treat. 2018 Feb;85:61-65. doi: 10.1016/j.jsat.2017.01.018. Epub 2017 Feb 22. J Subst Abuse Treat. 2018. PMID: 28236511 Free PMC article. Clinical Trial.

Neural correlates of adherence to extended-release naltrexone pharmacotherapy in heroin dependence.

Wang AL, Elman I, Lowen SB, Blady SJ, Lynch KG, Hyatt JM, O'Brien CP, Langleben DD. Wang AL, et al. Transl Psychiatry. 2015 Mar 17;5(3):e531. doi: 10.1038/tp.2015.20. Transl Psychiatry. 2015. PMID: 25781230 Free PMC article.

12 results

Page of 2

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

12 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

12 results

Results by year